ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,185Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 1945

$412K Total Retail Price of All Prescriptions

Rank: 232 out of 1945

487 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Minnesota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 18%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 537 514 89 1 2
SIMVASTATIN 448 417 75 2 1
OMEPRAZOLE 393 340 63 3 4
FUROSEMIDE 385 358 65 4 6
METOPROLOL TARTRATE 310 273 41 5 9
WARFARIN SODIUM 299 294* 46 6 11
ATENOLOL 281 276* 47 7 7
LEVOTHYROXINE SODIUM 277 244 34 8 3
ATORVASTATIN CALCIUM 272 252 42 9 10
POLYETHYLENE GLYCOL 3350 203 172 50 10 28
HYDROCHLOROTHIAZIDE 197 192* 46 11 8
METFORMIN HCL 188 183* 31 12 12
MIRTAZAPINE 188 175 30 12 39
POTASSIUM CHLORIDE 169 157 23 14 17
AMLODIPINE BESYLATE 159 143 27 15 5
NAMENDA 148 148 11 16 45
TAMSULOSIN HCL 139 139 20 17 24
CITALOPRAM HBR 136 123 26 18 18
GLIMEPIRIDE 136 136 22 18 52
FLUTICASONE PROPIONATE 133 117 52 20 33
GABAPENTIN 132 127* 18 21 15
METOPROLOL SUCCINATE 111 106* 18 22 13
LOSARTAN POTASSIUM 110 105* 18 23 16
CLOPIDOGREL 105 82 15 24 29
ALLOPURINOL 103 103 20 25 26
PANTOPRAZOLE SODIUM 96 91* 14 26 41
TRAMADOL HCL 95 90* 19 27 19
CRESTOR 89 84* 13 28 35
ALENDRONATE SODIUM 84 70 15 29 25
AZITHROMYCIN 81 76* 69 30 57
RANITIDINE HCL 74 <11 <11 31 31
ALPRAZOLAM 72 72 11 B 32 58
PRAVASTATIN SODIUM 72 67* 14 32 21
DIGOX 70 <11 <11 34 77
DOXAZOSIN MESYLATE 67 <11 <11 35 74
PREDNISONE 66 49 31 36 27
OXYBUTYNIN CHLORIDE 65 <11 <11 37 106
HYDROCODONE-ACETAMINOPHEN 62 48 23 S3 38 14
LANTUS SOLOSTAR 59 59 13 39 44
TERAZOSIN HCL 57 <11 <11 40 86
FLUOXETINE HCL 56 45 12 41 46
SPIRONOLACTONE 55 <11 <11 42 62
DIOVAN 52 <11 <11 43 59
FINASTERIDE 52 <11 <11 43 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 <11 <11 45 22
PROAIR HFA 50 18 15 46 36
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.